Leadership Overview
Apotex has 10 executives leading key functions including strategy, finance, operations, legal, and human resources.
Driven by a commitment to patient access, Apotex produces high-quality, affordable medicines globally, embodying a philosophy of accessible healthcare through pharmaceutical innovation and operational excellence.
Driven by a commitment to patient access, Apotex produces high-quality, affordable medicines globally, embodying a philosophy of accessible healthcare through pharmaceutical innovation and operational excellence.
Leadership Roles at Apotex
Jeff Watson - President & Chief Executive Officer
Jeff Watson, the President & Chief Executive Officer at Apotex, directs the overarching corporate strategy and operational execution. Overseeing all global business units, Watson ensures the company's mission of providing high-quality, affordable medicines is consistently met. This leadership role involves driving innovation in both generic and innovative pharmaceuticals, expanding market reach across diverse international territories, and maintaining Apotex's position as a proud Canadian global pharmaceutical leader. By aligning departmental objectives with long-term growth targets, Jeff Watson significantly impacts the company's financial health and its ability to serve patients worldwide. Watson's strategic vision guides the organization's response to evolving healthcare landscapes and regulatory environments, securing Apotex's future success and commitment to patient well-being.
Brian McClelland - Chief Financial Officer
Brian McClelland, the Chief Financial Officer at Apotex, manages the company's comprehensive financial strategy and fiscal operations. Overseeing all financial planning, reporting, and investment activities, McClelland ensures the sustainable growth and profitability required to produce high-quality, affordable medicines for global patients. This leadership position involves rigorous budget management, capital allocation, and risk assessment across Apotex's international markets. By maintaining strong financial discipline, Brian McClelland supports the company's expansion efforts and its commitment to providing accessible pharmaceutical solutions. McClelland's expertise is crucial in navigating complex global economic conditions and ensuring the financial integrity that underpins Apotex's mission.
Shama Doddawad - Head Chief Financial Officer, Finance ( Operations (India)
Shama Doddawad, the Head Chief Financial Officer, Finance ( Operations (India) at Apotex, directs financial operations and strategic fiscal planning specifically for the company's Indian operations. Overseeing all financial activities within India, Doddawad ensures compliance with local regulations and optimizes financial performance to support the production and distribution of high-quality, affordable medicines in the region. This role is critical for managing budgets, controlling costs, and identifying financial opportunities that align with Apotex's global mission. By providing expert financial oversight, Shama Doddawad contributes significantly to the operational efficiency and strategic growth of Apotex in the vital Indian market, reinforcing the company's commitment to patient access.
Lorena Ferino - Chief Information Officer
Lorena Ferino, the Chief Information Officer at Apotex, architects the company's global technology infrastructure and digital transformation initiatives. Overseeing all IT operations, Ferino ensures robust cybersecurity measures and efficient data management systems are in place to support Apotex's production and distribution of high-quality, affordable medicines. This critical role involves implementing innovative technological solutions that enhance operational efficiency across all departments, from research and development to global supply chain logistics. By driving digital integration, Lorena Ferino enables seamless collaboration among international teams and strengthens the company's ability to respond to market demands. Ferino's leadership ensures that Apotex leverages cutting-edge technology to maintain its competitive edge and uphold its commitment to patient access worldwide.
Robert Shapiro - International Chief of Staff & Head of Strategy
Robert Shapiro, the International Chief of Staff & Head of Strategy at Apotex, spearheads strategic initiatives and operational alignment across global markets. Overseeing the development and execution of long-term strategic plans, Shapiro ensures Apotex's continued leadership in producing high-quality, affordable medicines worldwide. This role involves close collaboration with executive leadership to identify new growth opportunities, optimize business processes, and enhance market penetration in key international regions. By translating strategic vision into actionable plans, Robert Shapiro drives operational excellence and supports the company's mission of improving patient access to essential pharmaceuticals. Shapiro's strategic guidance is fundamental to Apotex's global expansion and its commitment to innovation.
Marilyn Greene - Coordinator, Chief Revenue Officer Client Services
Marilyn Greene, the Coordinator, Chief Revenue Officer Client Services at Apotex, manages and enhances client relationships to drive revenue growth and ensure exceptional service delivery. Overseeing key client interactions and service protocols, Greene supports the company's objective of making high-quality, affordable medicines accessible globally. This position involves coordinating communication between clients and internal revenue-generating departments, ensuring client needs are met efficiently and effectively. By fostering strong client partnerships, Marilyn Greene directly contributes to Apotex's market presence and its ability to expand its reach. Greene's focus on client satisfaction is integral to maintaining Apotex's reputation and achieving its revenue targets.
Carina Vassilieva - Chief Human Resources Officer
Carina Vassilieva, the Chief Human Resources Officer at Apotex, leads the global human resources strategy, focusing on talent acquisition, development, and organizational culture. Overseeing all HR functions, Vassilieva ensures Apotex attracts and retains the skilled workforce necessary to produce high-quality, affordable medicines for patients worldwide. This leadership role involves developing policies that support employee well-being, foster diversity and inclusion, and align human capital with the company's strategic objectives. By cultivating a robust talent pipeline and promoting a positive work environment, Carina Vassilieva is instrumental in driving operational excellence and supporting Apotex's mission of accessible healthcare. Vassilieva's expertise ensures the company's most valuable asset—its people—are empowered to achieve Apotex's goals.
Jeffrey Launay - HR Vice President & Chief of Staff
Jeffrey Launay, the HR Vice President & Chief of Staff at Apotex, provides strategic support to the Chief Human Resources Officer and oversees key HR initiatives. Managing critical projects and ensuring operational efficiency within the HR department, Launay contributes to Apotex's ability to attract and retain top talent for the production of high-quality, affordable medicines. This role involves coordinating cross-functional HR projects, implementing new HR technologies, and ensuring seamless execution of talent management strategies across global operations. By bridging strategic HR objectives with practical implementation, Jeffrey Launay enhances the effectiveness of the human resources function. Launay's contributions are vital to maintaining a strong organizational culture and supporting Apotex's mission.
Francesco Tallarico - Chief Legal Officer
Francesco Tallarico, the Chief Legal Officer at Apotex, directs all legal affairs and ensures compliance with global regulatory standards. Overseeing the legal framework for Apotex's operations, Tallarico safeguards the company's interests while facilitating the production and distribution of high-quality, affordable medicines worldwide. This critical position involves managing intellectual property, corporate governance, litigation, and international legal compliance. By providing expert legal counsel, Francesco Tallarico supports strategic decision-making and mitigates risks across Apotex's diverse markets. Tallarico's leadership ensures that Apotex operates with integrity and adheres to the highest legal and ethical standards, reinforcing its commitment to patient access and global health.
Ariel Alon - Chief Operations Officer
Ariel Alon, the Chief Operations Officer at Apotex, oversees the company's global manufacturing, supply chain, and operational efficiency. Directing all aspects of production and logistics, Alon ensures the consistent delivery of high-quality, affordable medicines to patients around the world. This leadership role involves optimizing manufacturing processes, managing inventory, and implementing robust supply chain strategies to meet global demand. By driving operational excellence, Ariel Alon enhances Apotex's capacity to scale its production and maintain cost-effectiveness, directly supporting the company's mission of accessible healthcare. Alon's focus on operational integrity is fundamental to Apotex's ability to serve diverse international markets reliably.
Explore Leadership Teams in Manufacturing
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.
Company Leadership ES
SS
BH
IOLCP is a leading manufacturer and supplier of Active Pharmaceutical Ingredients (API) and specialty chemicals, including Ethyl Acetate, which is recognized for its environmentally friendly properties. The company serves pharmaceutical companies globally by providing essential products for key medicines and is committed to sustainable practices and corporate social responsibility. With a strong focus on research and development, IOLCP aims to expand its value-added services in the API market while fostering green chemistry. The organization prides itself on its dedicated workforce and aims to create lasting value for both the planet and communities.
Company Leadership DS
PK
Founded in 1974, New England BioLabs is a privately held company that produces and supplies recombinant and native enzyme reagents for the life science research, as well as providing solutions supporting genome editing, synthetic biology, and next-generation sequencing. NEB also provides free access to research tools such as REBASE, InBASE, and Polbase. The company is headquartered in Ipswitch, Massachusetts.
Company Leadership SR
LB
Parabolic Drugs Limited is a vertically integrated, research-based pharmaceutical manufacturer and exporter, specializing in the production of over 50 active pharmaceutical ingredients (APIs) and intermediates across various therapeutic segments. The company operates four large-scale facilities, including three state-of-the-art manufacturing plants and a custom synthesis and R&D center. With a focus on backward and forward integration, world-class infrastructure, and strong R&D capabilities, Parabolic Drugs is committed to delivering high-quality products. Their diverse product portfolio is supported by intellectual property rights, including Drug Master Files (DMFs) and patents for novel processes.
Company Leadership AN
AJ
VG
YB
Frequently Asked Questions Regarding Apotex Top Executives and Leadership Team
